Skip to main content

Bank of New York Mellon Corp

Bank

Position in TGTX — Tg Therapeutics, Inc.

CIK 1390777 NEW YORK, NY

Position in TGTX

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$29,476,268
+$2,694,700 QoQ
Shares Held
887,305
-1.2% QoQ
Ownership
0.580%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,725,512 across 270 Biotechnology names. TGTX ranks #26 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TGTX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $29,476,268 887,305
2025-12-31 $26,781,568 898,409
2025-09-30 $31,520,902 872,551
2025-06-30 $32,624,029 906,475
2025-03-31 $35,203,099 892,800
2024-12-31 $27,796,984 923,488
2024-09-30 $19,549,569 835,809
2024-06-30 $8,959,841 503,645
2024-03-31 $6,755,093 444,122
2023-12-31 $8,090,161 473,663
2023-09-30 $4,846,248 579,695
2023-06-30 $14,646,629 589,639
2023-03-31 $7,057,262 469,233
2022-12-31 $5,874,740 496,597
2022-09-30 $2,669,190 450,877
2022-06-30 $1,694,796 398,776
2022-03-31 $5,059,831 532,054
2021-12-31 $10,109,919 532,101
2021-09-30 $18,802,466 564,978
2021-06-30 $20,640,155 532,100
2021-03-31 $24,585,949 510,082
2020-09-30 $12,478,641 466,317
2020-06-30 $8,489,732 435,818
2020-03-31 $3,570,934 362,900